文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症监护中抗菌药物管理项目的长期可持续性与接受度:一项回顾性队列研究

Long-Term Sustainability and Acceptance of Antimicrobial Stewardship in Intensive Care: A Retrospective Cohort Study.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论一项持续近10年的ICU抗菌药物管理审计反馈项目建议率为36%,接受率稳定在67%,提示需长期坚持并关注特殊单元与经验性治疗场景。

该回顾性队列研究在 urban academic medical institution 的ICU人群中评估抗菌药物管理项目(ASP)审计反馈的长期 uptake。研究期间共完成7,749次抗生素评估,其中2,826次(36%)提出调整治疗建议;建议接受率为67%(1,895/2,826),且在研究期间保持稳定。住院时间≤5天、入住心血管或烧伤外科、既往抗生素使用>5天、评估氨基糖苷类/碳青霉烯类/万古霉素(对照头孢曲松)与更高建议概率相关;入住level 3 ICU与更高接受率相关,而烧伤外科、肺炎(社区获得性或呼吸机相关性)、感染来源不明及特定建议类型(窄谱、改变剂型、更换药物 vs 改变剂量)与更低接受率相关。结论支持长期保持审计反馈、更频繁建议调整潜在肾毒性药物、加强特殊护理单元的努力以及进一步研究通常无病原学确认的经验性治疗感染源。

要点

  • ASP在近10年间完成7,749次抗生素评估,2,826次(36%)提出调整治疗建议,建议接受率67%(1,895/2,826)且研究期间稳定。
  • 与头孢曲松相比,评估氨基糖苷类(OR 2.91)、碳青霉烯类(OR 1.93)和万古霉素(OR 2.71)更可能产生调整治疗建议。
  • 入住level 3 ICU与建议接受可能性更高相关(OR 1.50),而烧伤外科(OR 0.64)、肺炎(社区获得性OR 0.64;呼吸机相关性OR 0.65)、感染来源不明(OR 0.66)与更低接受率相关。
  • 建议类型中,窄谱(OR 0.65)、改变剂型(OR 0.42)、更换药物(OR 0.63)相较改变剂量与更低接受率相关。
  • 住院时间≤5天(OR 1.15)、心血管(OR 1.37)或烧伤外科(OR 1.88)入院、既往抗生素使用>5天(OR 1.33)与更高建议概率相关。

适用人群与场景

  • 2010年6月至2019年9月期间入住ICU并接受抗菌药物管理项目建议的患者。
  • 场景为 urban, academic medical institution 的ICU。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 回顾性队列研究,纳入接受ASP建议的ICU患者,研究期间ASP提供7,749次抗生素评估,2,826次(36%)提出调整治疗建议。
  • 建议接受率为67%(1,895/2,826),且在研究期间保持稳定。
  • 与更高建议概率相关的因素:住院时间≤5天(OR 1.15;95%CI 1.00-1.32)、入住心血管(OR 1.37;95%CI 1.06-1.76)或烧伤外科(OR 1.88;95%CI 1.50-2.36)vs 普通内科、既往抗生素使用>5天(OR 1.33;95%CI 1.10-1.60)。
  • 与头孢曲松相比,评估氨基糖苷类(OR 2.91;95%CI 1.85-4.89)、碳青霉烯类(OR 1.93;95%CI 1.54-2.41)、万古霉素(OR 2.71;95%CI 2.19-3.36)更可能产生调整治疗建议。
  • 入住level 3 ICU与更高建议接受率相关(OR 1.50;95%CI 1.14-1.97)。
  • 与更低接受率相关的因素:烧伤外科(OR 0.64;95%CI 0.45-0.91)、肺炎(社区获得性OR 0.64;95%CI 0.42-0.97;呼吸机相关性OR 0.65;95%CI 0.44-0.94)、感染来源不明(OR 0.66;95%CI 0.48-0.92)、建议类型为窄谱(OR 0.65;95%CI 0.45-0.94)、改变剂型(OR 0.42;95%CI 0.27-0.64)、更换药物(OR 0.63;95%CI 0

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 原文未述局限性。

对床旁实践的改变

  • 该研究提示ASP审计反馈在ICU中可长期维持建议率与接受率,支持持续存在审计反馈。
  • 研究结果支持更频繁地建议调整潜在肾毒性药物(如氨基糖苷类、万古霉素),并加强特殊护理单元(如烧伤外科)的ASP工作。
  • 需进一步研究通常无病原学确认即治疗的感染源(如肺炎、感染来源不明)以改善ASP建议接受度。
  • 原文未提及适用与不适用人群的明确界定。

指南或共识出处

  • Long-Term Sustainability and Acceptance of Antimicrobial Stewardship in Intensive Care: A Retrospective Cohort Study. Crit Care Med.

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate long-term uptake of an antimicrobial stewardship audit-and-feedback program along with potential predictors of stewardship suggestions and acceptance across a diverse ICU population.

DESIGN: A retrospective cohort study.

SETTING: An urban, academic medical institution.

PATIENTS: Patients admitted to an ICU who received an antimicrobial stewardship program suggestion between June 2010 and September 2019.

MEASUREMENTS AND MAIN RESULTS: The antimicrobial stewardship program provided 7,749 antibiotic assessments over the study period and made a suggestion to alter therapy in 2,826 (36%). Factors associated with a higher likelihood of receiving a suggestion to alter therapy included shorter hospital length of stay prior to antimicrobial stewardship program review (odds ratio 1.15 for ≤ 5 d; 95% CI 1.00-1.32), admission to cardiovascular (1.37; 1.06-1.76) or burn surgery (1.88; 1.50-2.36) versus general medicine, and preceding duration of antibiotic use greater than 5 days (1.33; 1.10-1.60). Assessment of aminoglycosides (2.91; 1.85-4.89), carbapenems (1.93; 1.54-2.41), and vancomycin (2.71; 2.19-3.36) versus ceftriaxone was more likely to result in suggestions to alter therapy. The suggestion acceptance rate was 67% (1,895/2,826), which was stable throughout the study period. Admission to a level 3 ICU was associated with higher likelihood of acceptance of suggestions (1.50; 1.14-1.97). Factors associated with lower acceptance rates were admission to burn surgery (0.64; 0.45-0.91), treatment of pneumonia (0.64; 0.42-0.97 for community-acquired and 0.65; 0.44-0.94 for ventilator-acquired), unknown source of infection (0.66; 0.48-0.92), and suggestion types of "narrow spectrum" (0.65; 0.45-0.94), "change formulation of antibiotic" (0.42; 0.27-0.64), or "change agent of therapy" (0.63; 0.40-0.97) versus "change of dose".

CONCLUSIONS: An antimicrobial stewardship program implemented over a decade resulted in sustained suggestion and acceptance rates. These findings support the need for a persistent presence of audit-and-feedback over time with more frequent suggestions to alter potentially nephrotoxic agents, increased efforts toward specialized care units, and further work approaching infectious sources that are typically treated without pathogen confirmation and identification.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Sehgal P, Elligsen M, Lo J, et al. Long-Term Sustainability and Acceptance of Antimicrobial Stewardship in Intensive Care: A Retrospective Cohort Study. Crit Care Med. 2021. PMID: 33060503. doi:10.1097/CCM.0000000000004698

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。